Published in Eur Respir J on March 01, 1989
Do biophysical properties of the airway smooth muscle in culture predict airway hyperresponsiveness? Am J Respir Cell Mol Biol (2006) 1.78
Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason? Am J Respir Cell Mol Biol (2007) 1.39
Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax (1996) 1.21
A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness. J Theor Biol (2010) 1.18
Bronchospasm and its biophysical basis in airway smooth muscle. Respir Res (2004) 1.11
Airway smooth muscle and bronchospasm: fluctuating, fluidizing, freezing. Respir Physiol Neurobiol (2008) 1.01
Clinical implications of airway hyperresponsiveness in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.98
Alcohol feeding blocks methacholine-induced airway responsiveness in mice. Am J Physiol Lung Cell Mol Physiol (2008) 0.95
Acid aspiration-induced airways hyperresponsiveness in mice. J Appl Physiol (1985) (2009) 0.91
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax (1991) 0.86
Methodology of bronchial responsiveness. Thorax (1998) 0.85
Effects of dexamethasone on airway hyper-responsiveness to the adenosine A1 receptor agonist cyclo-pentyl adenosine in an allergic rabbit model. Br J Pharmacol (1999) 0.82
Quantifying parenchymal tethering in a finite element simulation of a human lung slice under bronchoconstriction. Respir Physiol Neurobiol (2012) 0.81
Biophysical basis for airway hyperresponsiveness. Can J Physiol Pharmacol (2007) 0.81
Features of cough variant asthma and classic asthma during methacholine-induced brochoconstriction: a cross-sectional study. Cough (2009) 0.81
Multiscale mathematical models of airway constriction and disease. Pulm Pharmacol Ther (2011) 0.80
The orl rat is more responsive to methacholine challenge than wild type. Pulm Pharmacol Ther (2014) 0.76
Asthma-snapshot or motion picture? Front Genet (2013) 0.76
The relationship between inspiratory lung function parameters and airway hyper-responsiveness in subjects with mild to moderate COPD. BMC Res Notes (2012) 0.75
Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects. Thorax (1997) 0.75
Effects of fluticasone propionate on arachidonic acid metabolites in BAL-fluid and methacholine dose-response curves in non-smoking atopic asthmatics. Mediators Inflamm (1996) 0.75
Variability of the plateau response to methacholine in subjects without respiratory symptoms. Thorax (1993) 0.75
Time intervals (3' or 5') between dose steps can influence methacholine challenge test. Lung (2005) 0.75
The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study. Respir Res (2017) 0.75
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J (2005) 3.05
Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med (1992) 2.52
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J (1996) 2.05
Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med (2001) 1.88
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy (2008) 1.31
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J Allergy Clin Immunol (1995) 1.26
Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax (1999) 1.20
Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis (1993) 1.16
Three phenotypes of adult-onset asthma. Allergy (2013) 1.15
Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl (2002) 1.10
EAACI position statement on asthma exacerbations and severe asthma. Allergy (2013) 1.07
Auranofin in the treatment of steroid dependent asthma: a double blind study. Thorax (1992) 1.05
Psychopathology in patients with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med (2001) 1.04
Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med (1998) 1.03
Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med (2000) 1.03
Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol (2001) 1.02
External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy (2011) 1.02
CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects. Clin Exp Allergy (1998) 0.99
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J (2006) 0.98
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med (1999) 0.95
The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis (1992) 0.92
The excretion of leukotriene E4 into urine following inhalation of leukotriene D4 by human individuals. Biochem Biophys Res Commun (1987) 0.92
Current treatment of severe asthma. Clin Exp Allergy (2012) 0.90
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma. Eur Respir J (2008) 0.90
Similar psychological characteristics in mild and severe asthma. J Psychosom Res (2001) 0.89
Flow-dependency of exhaled nitric oxide in children with asthma and cystic fibrosis. Eur Respir J (1999) 0.88
High-altitude treatment: a therapeutic option for patients with severe, refractory asthma? Clin Exp Allergy (2011) 0.87
The severity of breathlessness during challenges with inhaled methacholine and hypertonic saline in atopic asthmatic subjects. The relationship with deep breath-induced bronchodilation. Am J Respir Crit Care Med (1995) 0.87
Quantification of theophylline-induced eosinopenia and hypokalaemia in healthy volunteers. Clin Pharmacokinet (1992) 0.86
Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma. Respir Med (2006) 0.85
Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstriction. Am J Respir Crit Care Med (2001) 0.84
Extracellular matrix in airway smooth muscle is associated with dynamics of airway function in asthma. Allergy (2012) 0.84
Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy (2014) 0.83
Non-atopic males with adult onset asthma are at risk of persistent airflow limitation. Clin Exp Allergy (2012) 0.83
The use of induced sputum in clinical trials. Eur Respir J Suppl (2002) 0.81
Gene expression profiling of laser microdissected airway smooth muscle tissue in asthma and atopy. Allergy (2014) 0.80
The determinants of airway hyperresponsiveness to hypertonic saline in atopic asthma in vivo. Relationship with sub-populations of peripheral blood leucocytes. Clin Exp Allergy (1993) 0.78
The long-term effect of nedocromil sodium on the maximal degree of airway narrowing to methacholine in atopic asthmatic subjects. Clin Exp Allergy (1992) 0.78
The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 0.77
Repeated virus identification in the airways of patients with mild and severe asthma during prospective follow-up. Allergy (2011) 0.77
Small airways, big challenge. Eur Respir Rev (2011) 0.75
[Pruritus ani; an irritating problem]. Ned Tijdschr Geneeskd (1988) 0.75
[Asthma: theory and practice in the year 1992]. Ned Tijdschr Geneeskd (1992) 0.75
Anti-leukotriene therapy in asthma. Neth J Med (1998) 0.75
The combined effects of histamine and methacholine on the maximal degree of airway narrowing in normal humans in vivo. Eur Respir J (1988) 0.75
Alternative strategies in the treatment of bronchial asthma. Clin Exp Allergy (2000) 0.75